Related Experiment Video
Updated: May 5, 2026
From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
Published on: October 19, 2014
Application of two-dimensional gel-based mass spectrometry to functionally dissect resistance to targeted cancer
Oliver Klein1, Nadine Rohwer, Katja Freitag de Molina
1Berlin-Brandenburg Center for Regenerative Therapies, Charité - Universitätsmedizin Berlin, Berlin, Germany; Core Unit Proteomics, Berlin-Brandenburg Center for Regenerative Therapies, Berlin, Germany; Institute of Medical and Human Genetics, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Purpose:
The majority of gastric cancers are diagnosed at advanced stages, characterized by robust therapy resistance. The oncoprotein hypoxia-inducible factor 1 (HIF-1) is associated with therapy resistance, partly via activation of the DNA damage response. We have noted a robust ability of gastric cancer cells to functionally compensate the loss of HIF-1 in vitro. The purpose of this study was to identify molecular pathways that underlie this compensation.
Experimental Design:
We performed 2DE to compare the nuclear proteome of wild-type and HIF-1-deficient gastric cancer cells. Differently expressed protein spots were identified via MS). After bioinformatic evaluation, functional validation of selected identified pathways was performed.
Results:
2DE displayed a total of 2523 protein spots, from which 87 were identified as regulated by HIF-1. Seventy of the identified spots were different proteins and 17 were isoforms. Bioinformatic analyses revealed that a significant amount of the identified proteins were related to cellular survival pathways. Specifically, members of the proteasome pathway were found upregulated upon loss of HIF-1. Combined inhibition of HIF-1 and the proteasome inflicted significant DNA damage, supporting the hypothesis that the proteasome is of functional importance to compensate the loss of HIF-1.
Conclusions And Clinical Relevance:
Our data show robust and functional changes of the nuclear proteome upon inactivation of the HIF-1 oncoprotein in gastric cancer cells. We propose that 2DE-MS represents a useful tool to functionally dissect resistance mechanisms to targeted therapy and to identify novel targets for antiproliferative combination therapy.
Insights
Gastric cancer cells compensate for the loss of hypoxia-inducible factor 1 (HIF-1) by upregulating proteasome pathways. Inhibiting both HIF-1 and the proteasome causes significant DNA damage, revealing a potential therapeutic strategy.
Area of Science:
- Oncology
- Molecular Biology
- Proteomics
Background:
- Advanced gastric cancer exhibits significant therapy resistance.
- Hypoxia-inducible factor 1 (HIF-1) oncoprotein is linked to therapy resistance through DNA damage response activation.
- Gastric cancer cells demonstrate functional compensation for HIF-1 loss in vitro.
Purpose of the Study:
- To identify molecular pathways responsible for HIF-1 compensation in gastric cancer cells.
- To investigate the functional significance of these compensatory pathways in therapy resistance.
Main Methods:
- Comparative nuclear proteome analysis using 2D gel electrophoresis (2DE) between wild-type and HIF-1-deficient gastric cancer cells.
- Protein identification through mass spectrometry (MS).
- Bioinformatic analysis and functional validation of identified pathways.
Main Results:
- 2DE identified 87 protein spots regulated by HIF-1, including 70 distinct proteins and 17 isoforms.
- Bioinformatic analysis indicated that many identified proteins are involved in cellular survival pathways.
- Proteasome pathway members were upregulated upon HIF-1 loss, and combined inhibition of HIF-1 and proteasome induced significant DNA damage.
Conclusions:
- Inactivation of HIF-1 in gastric cancer cells leads to substantial functional alterations in the nuclear proteome.
- The proteasome pathway plays a crucial role in compensating for HIF-1 loss.
- 2DE-MS is a valuable technique for dissecting therapy resistance mechanisms and identifying novel therapeutic targets for combination therapy.
More Related Videos
08:08Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors
Published on: February 27, 2015
12:34Two-dimensional Gel Electrophoresis Coupled with Mass Spectrometry Methods for an Analysis of Human Pituitary Adenoma Tissue Proteome
Published on: April 2, 2018
Related Concept Videos
01:22Two-dimensional Gel Electrophoresis
The first dimension separation uses the isoelectric focusing or IEF technique performed on immobilized pH gradient (IPG) strips that separate proteins according to their isoelectric points.
Biological samples, such...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...